Covered recipient · General Payments record
DEREK DEAN
General Payments · PY2023–2024
$452.49
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $206.93 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $61.70 | 3 |
| Astellas Pharma US Inc | $40.54 | 2 |
| Biogen, Inc. | $28.13 | 1 |
| PFIZER INC. | $22.74 | 1 |
| MAYNE PHARMA COMMERCIAL LLC | $22.74 | 1 |
| Evofem Biosciences, Inc. | $17.40 | 1 |
| Minerva Surgical, Inc | $13.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.32 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103615454 | CMS |
| ABBVIE INC. | $18.28 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103615456 | CMS |
| ABBVIE INC. | $26.10 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103615458 | CMS |
| Astellas Pharma US Inc | $16.47 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140286601 | CMS |
| Astellas Pharma US Inc | $24.07 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140287659 | CMS |
| Biogen, Inc. | $28.13 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104870746 | CMS |
| Evofem Biosciences, Inc. | $17.40 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091286568 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $22.74 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154690075 | CMS |
| Minerva Surgical, Inc | $13.68 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1085611569 | CMS |
| PFIZER INC. | $22.74 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130987052 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.